1h Free Analyst Time
The global peripheral neuropathy treatment market is forecasted to grow by USD 504.10 million during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, rising awareness of peripheral neuropathy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global peripheral neuropathy treatment market is segmented as below:
By Type
- Diabetic
- Chemotherapy
- Others
By Therapy
- Pharmacological therapies
- Non pharmacological therapies
By Diagnostic Methods
- Blood test
- Biopsy
- Imaging
By End-User
- Hospitals and clinics
- Retail pharmacy
- Online pharmacy
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global peripheral neuropathy treatment market covers the following areas:
- Global peripheral neuropathy treatment market sizing
- Global peripheral neuropathy treatment market forecast
- Global peripheral neuropathy treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Peripheral Neuropathy Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2020 - 2024 ($ thousand)
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Diagnostic Methods Segment 2020 - 2024 ($ thousand)
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
6.1 Impact of AI on Global Peripheral Neuropathy Treatment Market
6.2 Impact of Geopolitical Conflicts on Global Peripheral Neuropathy Treatment Market
6.2 Impact of Geopolitical Conflicts on Global Peripheral Neuropathy Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Diabetic - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Diabetic - Market size and forecast 2025-2030 ($ thousand)
- Chart on Diabetic - Year-over-year growth 2025-2030 (%)
- Data Table on Diabetic - Year-over-year growth 2025-2030 (%)
- Chart on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
- Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ thousand)
- Data Table on Market opportunity by Type ($ thousand)
9 Market Segmentation by Therapy
9.1 Market segments
- Chart on Therapy - Market share 2025-2030 (%)
- Data Table on Therapy - Market share 2025-2030 (%)
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
- Chart on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
- Chart on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
- Chart on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
- Chart on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Therapy ($ thousand)
- Data Table on Market opportunity by Therapy ($ thousand)
10 Market Segmentation by Diagnostic Methods
10.1 Market segments
- Chart on Diagnostic Methods - Market share 2025-2030 (%)
- Data Table on Diagnostic Methods - Market share 2025-2030 (%)
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
- Chart on Blood test - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Blood test - Market size and forecast 2025-2030 ($ thousand)
- Chart on Blood test - Year-over-year growth 2025-2030 (%)
- Data Table on Blood test - Year-over-year growth 2025-2030 (%)
- Chart on Biopsy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Biopsy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Biopsy - Year-over-year growth 2025-2030 (%)
- Data Table on Biopsy - Year-over-year growth 2025-2030 (%)
- Chart on Imaging - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Imaging - Market size and forecast 2025-2030 ($ thousand)
- Chart on Imaging - Year-over-year growth 2025-2030 (%)
- Data Table on Imaging - Year-over-year growth 2025-2030 (%)
- Market opportunity by Diagnostic Methods ($ thousand)
- Data Table on Market opportunity by Diagnostic Methods ($ thousand)
11 Market Segmentation by End-user
11.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ thousand)
- Data Table on Market opportunity by End-user ($ thousand)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ thousand)
- Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ thousand)
- Data Table on US - Market size and forecast 2025-2030 ($ thousand)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ thousand)
- Data Table on France - Market size and forecast 2025-2030 ($ thousand)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ thousand)
- Data Table on China - Market size and forecast 2025-2030 ($ thousand)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ thousand)
- Data Table on India - Market size and forecast 2025-2030 ($ thousand)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Increasing prevalence of peripheral neuropathy
- Recent drug approvals for peripheral neuropathy
- Rising awareness of peripheral neuropathy
- Side effects of medications used for peripheral neuropathy
- Complications involved in diagnosis of peripheral neuropathy
- Stringent regulations and product discontinuation
- Impact of drivers and challenges in 2025 and 2030
- Strong drug pipeline is augmenting market growth
- Technological advances with new formulations of drugs
- Increase in research and development associated with peripheral neuropathy treatment
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key news
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key news
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Diagnostic Methods Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Diabetic - Market size and forecast 2025-2030 ($ thousand)
Exhibit 45: Data Table on Diabetic - Market size and forecast 2025-2030 ($ thousand)
Exhibit 46: Chart on Diabetic - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Diabetic - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 49: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 50: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 53: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 54: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 56: Market opportunity by Type ($ thousand)
Exhibit 57: Data Table on Market opportunity by Type ($ thousand)
Exhibit 58: Chart on Therapy - Market share 2025-2030 (%)
Exhibit 59: Data Table on Therapy - Market share 2025-2030 (%)
Exhibit 60: Chart on Comparison by Therapy
Exhibit 61: Data Table on Comparison by Therapy
Exhibit 62: Chart on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 63: Data Table on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 64: Chart on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 67: Data Table on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 68: Chart on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Market opportunity by Therapy ($ thousand)
Exhibit 71: Data Table on Market opportunity by Therapy ($ thousand)
Exhibit 72: Chart on Diagnostic Methods - Market share 2025-2030 (%)
Exhibit 73: Data Table on Diagnostic Methods - Market share 2025-2030 (%)
Exhibit 74: Chart on Comparison by Diagnostic Methods
Exhibit 75: Data Table on Comparison by Diagnostic Methods
Exhibit 76: Chart on Blood test - Market size and forecast 2025-2030 ($ thousand)
Exhibit 77: Data Table on Blood test - Market size and forecast 2025-2030 ($ thousand)
Exhibit 78: Chart on Blood test - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Blood test - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Biopsy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 81: Data Table on Biopsy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 82: Chart on Biopsy - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Biopsy - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Imaging - Market size and forecast 2025-2030 ($ thousand)
Exhibit 85: Data Table on Imaging - Market size and forecast 2025-2030 ($ thousand)
Exhibit 86: Chart on Imaging - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Imaging - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Diagnostic Methods ($ thousand)
Exhibit 89: Data Table on Market opportunity by Diagnostic Methods ($ thousand)
Exhibit 90: Chart on End-user - Market share 2025-2030 (%)
Exhibit 91: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by End-user
Exhibit 93: Data Table on Comparison by End-user
Exhibit 94: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 95: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 99: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 100: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 103: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 104: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by End-user ($ thousand)
Exhibit 107: Data Table on Market opportunity by End-user ($ thousand)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 172: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 176: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 210: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 211: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 226: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 227: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ thousand)
Exhibit 230: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: Abbott Laboratories - Overview
Exhibit 239: Abbott Laboratories - Business segments
Exhibit 240: Abbott Laboratories - Key news
Exhibit 241: Abbott Laboratories - Key offerings
Exhibit 242: Abbott Laboratories - Segment focus
Exhibit 243: SWOT
Exhibit 244: Boston Scientific Corp. - Overview
Exhibit 245: Boston Scientific Corp. - Business segments
Exhibit 246: Boston Scientific Corp. - Key news
Exhibit 247: Boston Scientific Corp. - Key offerings
Exhibit 248: Boston Scientific Corp. - Segment focus
Exhibit 249: SWOT
Exhibit 250: Cipla Inc. - Overview
Exhibit 251: Cipla Inc. - Business segments
Exhibit 252: Cipla Inc. - Key news
Exhibit 253: Cipla Inc. - Key offerings
Exhibit 254: Cipla Inc. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 257: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 258: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 259: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 260: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 263: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 264: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 265: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 266: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Eli Lilly and Co. - Overview
Exhibit 269: Eli Lilly and Co. - Product / Service
Exhibit 270: Eli Lilly and Co. - Key offerings
Exhibit 271: SWOT
Exhibit 272: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 273: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 274: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 275: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Lupin Ltd. - Overview
Exhibit 278: Lupin Ltd. - Business segments
Exhibit 279: Lupin Ltd. - Key news
Exhibit 280: Lupin Ltd. - Key offerings
Exhibit 281: Lupin Ltd. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Medtronic Plc - Overview
Exhibit 284: Medtronic Plc - Business segments
Exhibit 285: Medtronic Plc - Key news
Exhibit 286: Medtronic Plc - Key offerings
Exhibit 287: Medtronic Plc - Segment focus
Exhibit 288: SWOT
Exhibit 289: Pfizer Inc. - Overview
Exhibit 290: Pfizer Inc. - Business segments
Exhibit 291: Pfizer Inc. - Key news
Exhibit 292: Pfizer Inc. - Key offerings
Exhibit 293: Pfizer Inc. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Sanofi SA - Overview
Exhibit 296: Sanofi SA - Business segments
Exhibit 297: Sanofi SA - Key news
Exhibit 298: Sanofi SA - Key offerings
Exhibit 299: Sanofi SA - Segment focus
Exhibit 300: SWOT
Exhibit 301: Sun Pharmaceutical Industries - Overview
Exhibit 302: Sun Pharmaceutical Industries - Business segments
Exhibit 303: Sun Pharmaceutical Industries - Key news
Exhibit 304: Sun Pharmaceutical Industries - Key offerings
Exhibit 305: Sun Pharmaceutical Industries - Segment focus
Exhibit 306: SWOT
Exhibit 307: Teva Pharmaceutical Ltd. - Overview
Exhibit 308: Teva Pharmaceutical Ltd. - Business segments
Exhibit 309: Teva Pharmaceutical Ltd. - Key news
Exhibit 310: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 311: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Viatris Inc. - Overview
Exhibit 314: Viatris Inc. - Business segments
Exhibit 315: Viatris Inc. - Key news
Exhibit 316: Viatris Inc. - Key offerings
Exhibit 317: Viatris Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Zydus Lifesciences Ltd. - Overview
Exhibit 320: Zydus Lifesciences Ltd. - Business segments
Exhibit 321: Zydus Lifesciences Ltd. - Key news
Exhibit 322: Zydus Lifesciences Ltd. - Key offerings
Exhibit 323: Zydus Lifesciences Ltd. - Segment focus
Exhibit 324: SWOT
Exhibit 325: Inclusions checklist
Exhibit 326: Exclusions checklist
Exhibit 327: Currency conversion rates for US$
Exhibit 328: Research methodology
Exhibit 329: Information sources
Exhibit 330: Data validation
Exhibit 331: Validation techniques employed for market sizing
Exhibit 332: Data synthesis
Exhibit 333: 360 degree market analysis
Exhibit 334: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Diagnostic Methods Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Diabetic - Market size and forecast 2025-2030 ($ thousand)
Exhibit 45: Data Table on Diabetic - Market size and forecast 2025-2030 ($ thousand)
Exhibit 46: Chart on Diabetic - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Diabetic - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 49: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 50: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 53: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 54: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 56: Market opportunity by Type ($ thousand)
Exhibit 57: Data Table on Market opportunity by Type ($ thousand)
Exhibit 58: Chart on Therapy - Market share 2025-2030 (%)
Exhibit 59: Data Table on Therapy - Market share 2025-2030 (%)
Exhibit 60: Chart on Comparison by Therapy
Exhibit 61: Data Table on Comparison by Therapy
Exhibit 62: Chart on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 63: Data Table on Pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 64: Chart on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 67: Data Table on Non pharmacological therapies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 68: Chart on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Non pharmacological therapies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Market opportunity by Therapy ($ thousand)
Exhibit 71: Data Table on Market opportunity by Therapy ($ thousand)
Exhibit 72: Chart on Diagnostic Methods - Market share 2025-2030 (%)
Exhibit 73: Data Table on Diagnostic Methods - Market share 2025-2030 (%)
Exhibit 74: Chart on Comparison by Diagnostic Methods
Exhibit 75: Data Table on Comparison by Diagnostic Methods
Exhibit 76: Chart on Blood test - Market size and forecast 2025-2030 ($ thousand)
Exhibit 77: Data Table on Blood test - Market size and forecast 2025-2030 ($ thousand)
Exhibit 78: Chart on Blood test - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Blood test - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Biopsy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 81: Data Table on Biopsy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 82: Chart on Biopsy - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Biopsy - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Imaging - Market size and forecast 2025-2030 ($ thousand)
Exhibit 85: Data Table on Imaging - Market size and forecast 2025-2030 ($ thousand)
Exhibit 86: Chart on Imaging - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Imaging - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Diagnostic Methods ($ thousand)
Exhibit 89: Data Table on Market opportunity by Diagnostic Methods ($ thousand)
Exhibit 90: Chart on End-user - Market share 2025-2030 (%)
Exhibit 91: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by End-user
Exhibit 93: Data Table on Comparison by End-user
Exhibit 94: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 95: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 99: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 100: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 103: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 104: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by End-user ($ thousand)
Exhibit 107: Data Table on Market opportunity by End-user ($ thousand)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 172: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 176: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 210: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 211: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 226: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 227: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ thousand)
Exhibit 230: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: Abbott Laboratories - Overview
Exhibit 239: Abbott Laboratories - Business segments
Exhibit 240: Abbott Laboratories - Key news
Exhibit 241: Abbott Laboratories - Key offerings
Exhibit 242: Abbott Laboratories - Segment focus
Exhibit 243: SWOT
Exhibit 244: Boston Scientific Corp. - Overview
Exhibit 245: Boston Scientific Corp. - Business segments
Exhibit 246: Boston Scientific Corp. - Key news
Exhibit 247: Boston Scientific Corp. - Key offerings
Exhibit 248: Boston Scientific Corp. - Segment focus
Exhibit 249: SWOT
Exhibit 250: Cipla Inc. - Overview
Exhibit 251: Cipla Inc. - Business segments
Exhibit 252: Cipla Inc. - Key news
Exhibit 253: Cipla Inc. - Key offerings
Exhibit 254: Cipla Inc. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 257: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 258: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 259: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 260: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 263: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 264: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 265: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 266: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Eli Lilly and Co. - Overview
Exhibit 269: Eli Lilly and Co. - Product / Service
Exhibit 270: Eli Lilly and Co. - Key offerings
Exhibit 271: SWOT
Exhibit 272: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 273: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 274: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 275: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Lupin Ltd. - Overview
Exhibit 278: Lupin Ltd. - Business segments
Exhibit 279: Lupin Ltd. - Key news
Exhibit 280: Lupin Ltd. - Key offerings
Exhibit 281: Lupin Ltd. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Medtronic Plc - Overview
Exhibit 284: Medtronic Plc - Business segments
Exhibit 285: Medtronic Plc - Key news
Exhibit 286: Medtronic Plc - Key offerings
Exhibit 287: Medtronic Plc - Segment focus
Exhibit 288: SWOT
Exhibit 289: Pfizer Inc. - Overview
Exhibit 290: Pfizer Inc. - Business segments
Exhibit 291: Pfizer Inc. - Key news
Exhibit 292: Pfizer Inc. - Key offerings
Exhibit 293: Pfizer Inc. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Sanofi SA - Overview
Exhibit 296: Sanofi SA - Business segments
Exhibit 297: Sanofi SA - Key news
Exhibit 298: Sanofi SA - Key offerings
Exhibit 299: Sanofi SA - Segment focus
Exhibit 300: SWOT
Exhibit 301: Sun Pharmaceutical Industries - Overview
Exhibit 302: Sun Pharmaceutical Industries - Business segments
Exhibit 303: Sun Pharmaceutical Industries - Key news
Exhibit 304: Sun Pharmaceutical Industries - Key offerings
Exhibit 305: Sun Pharmaceutical Industries - Segment focus
Exhibit 306: SWOT
Exhibit 307: Teva Pharmaceutical Ltd. - Overview
Exhibit 308: Teva Pharmaceutical Ltd. - Business segments
Exhibit 309: Teva Pharmaceutical Ltd. - Key news
Exhibit 310: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 311: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Viatris Inc. - Overview
Exhibit 314: Viatris Inc. - Business segments
Exhibit 315: Viatris Inc. - Key news
Exhibit 316: Viatris Inc. - Key offerings
Exhibit 317: Viatris Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Zydus Lifesciences Ltd. - Overview
Exhibit 320: Zydus Lifesciences Ltd. - Business segments
Exhibit 321: Zydus Lifesciences Ltd. - Key news
Exhibit 322: Zydus Lifesciences Ltd. - Key offerings
Exhibit 323: Zydus Lifesciences Ltd. - Segment focus
Exhibit 324: SWOT
Exhibit 325: Inclusions checklist
Exhibit 326: Exclusions checklist
Exhibit 327: Currency conversion rates for US$
Exhibit 328: Research methodology
Exhibit 329: Information sources
Exhibit 330: Data validation
Exhibit 331: Validation techniques employed for market sizing
Exhibit 332: Data synthesis
Exhibit 333: 360 degree market analysis
Exhibit 334: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global peripheral neuropathy treatment market: Abbott Laboratories, Aurobindo Pharma Ltd., Boston Scientific Corp., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Grunenthal GmbH, Hisamitsu Pharmaceutical Co, Lupin Ltd., Medtronic Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., UCB SA, Viatris Inc., Woerwag Pharma GmbH and Co, Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong drug pipeline is augmenting market growth."
According to the report, one of the major drivers for this market is the increasing prevalence of peripheral neuropathy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Aurobindo Pharma Ltd.
- Boston Scientific Corp.
- Cipla Inc.
- Daiichi Sankyo Co. Ltd.
- Dr. Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Glenmark Pharmaceuticals Ltd.
- Grunenthal GmbH
- Hisamitsu Pharmaceutical Co
- Lupin Ltd.
- Medtronic Plc
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- UCB SA
- Viatris Inc.
- Woerwag Pharma GmbH and Co
- Zydus Lifesciences Ltd.
